Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    10702749 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Effects and Response of LY2605541 in Patients With Type 1 Diabetes Mellitus (BIDO)
Conditions: Type 1 Diabetes Mellitus;   Healthy
Intervention: Drug: Insulin Glargine or LY2605541
2 Recruiting Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism
Condition: Mild Hypercortisolism
Intervention: Drug: Mifepristone
3 Active, not recruiting The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes
Condition: Gestational Diabetes Mellitus
Interventions: Drug: Liraglutide;   Drug: Placebo
4 Completed
Has Results
Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes
Condition: Diabetes Mellitus
Interventions: Drug: Insulin Detemir;   Drug: Insulin Glargine

Indicates status has not been verified in more than two years